{
  "ticker": "NVAX",
  "company_name": "Novavax, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT07079670",
      "title": "Safety and Immunogenicity of NVX-CoV2705",
      "status": "NOT_YET_RECRUITING",
      "phase": "PHASE3",
      "condition": "COVID-19, SARS-CoV-2 Infection",
      "start_date": "2025-10-16",
      "completion_date": "2026-06-16",
      "enrollment": 0,
      "sponsor": "Novavax"
    },
    {
      "nct_id": "NCT06065176",
      "title": "The Efficacy of the 2023-2024 Updated COVID-19 Vaccines Against COVID-19 Infection",
      "status": "COMPLETED",
      "phase": "PHASE4",
      "condition": "COVID-19, Vaccine-Preventable Diseases, SARS CoV 2 Infection, Upper Respiratory Tract Infection, Upper Respiratory Disease",
      "start_date": "2023-11-22",
      "completion_date": "2024-09-09",
      "enrollment": 0,
      "sponsor": "Sarang K. Yoon, DO, MOH"
    },
    {
      "nct_id": "NCT05135273",
      "title": "Study of the Transmission-Blocking Vaccine Pfs230D1-EPA/Matrix-M Against Malaria in Adults in Mali",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Malaria,Falciparum",
      "start_date": "2021-10-22",
      "completion_date": "2023-06-21",
      "enrollment": 0,
      "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)"
    },
    {
      "nct_id": "NCT04583995",
      "title": "A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United Kingdom",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "SARS-CoV-2 Infection, COVID-19",
      "start_date": "2020-09-28",
      "completion_date": "2022-03-29",
      "enrollment": 0,
      "sponsor": "Novavax"
    },
    {
      "nct_id": "NCT01561768",
      "title": "A Study to Evaluate the Immune Response and Safety of a Seasonal Virus-Like Particle Influenza Vaccine in Healthy Young Adults",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Influenza",
      "start_date": "2012-03",
      "completion_date": "2013-01",
      "enrollment": 0,
      "sponsor": "Novavax"
    },
    {
      "nct_id": "NCT06409663",
      "title": "A Strain Change Study for SARS-CoV-2 rS Vaccines",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Severe Acute Respiratory Syndrome Coronavirus 2 Infection",
      "start_date": "2024-10-14",
      "completion_date": "2025-04-17",
      "enrollment": 0,
      "sponsor": "Novavax"
    },
    {
      "nct_id": "NCT02247726",
      "title": "RSV F Vaccine Maternal Immunization Study in Healthy Third-trimester Pregnant Women.",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Respiratory Syncytial Virus Infections",
      "start_date": "2014-09",
      "completion_date": "2016-07",
      "enrollment": 0,
      "sponsor": "Novavax"
    },
    {
      "nct_id": "NCT05463068",
      "title": "Study to Compare the Immunogenicity and Safety of 3 Lots of NVX-CoV2373 in Adults",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "COVID-19, SARS-CoV-2 Infection",
      "start_date": "2022-07-11",
      "completion_date": "2022-09-01",
      "enrollment": 0,
      "sponsor": "Novavax"
    },
    {
      "nct_id": "NCT06482359",
      "title": "Lot Consistency Study of COVID-19 and Influenza Combination Vaccine",
      "status": "WITHDRAWN",
      "phase": "PHASE2, PHASE3",
      "condition": "COVID-19, Influenza",
      "start_date": "2025-02-01",
      "completion_date": "2026-05-17",
      "enrollment": 0,
      "sponsor": "Novavax"
    },
    {
      "nct_id": "NCT01960686",
      "title": "RSV F Dose-Ranging Study in Women",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Respiratory Syncytial Virus Infections",
      "start_date": "2013-10",
      "completion_date": "2014-04",
      "enrollment": 0,
      "sponsor": "Novavax"
    }
  ],
  "summary": {
    "total_trials": 50,
    "by_phase": {
      "PHASE3": 12,
      "PHASE4": 3,
      "PHASE1": 9,
      "PHASE2": 16,
      "PHASE2, PHASE3": 5,
      "PHASE1, PHASE2": 5
    },
    "by_status": {
      "NOT_YET_RECRUITING": 2,
      "COMPLETED": 41,
      "WITHDRAWN": 3,
      "ACTIVE_NOT_RECRUITING": 3,
      "TERMINATED": 1
    },
    "active_trials": 3,
    "completed_trials": 41,
    "conditions": [
      "Avian Influenza",
      "COVID-19",
      "COVID-19, Influenza",
      "COVID-19, SARS CoV 2 Infection",
      "COVID-19, SARS-CoV-2 Infection",
      "COVID-19, Sars-CoV-2 Infection",
      "COVID-19, Vaccine-Preventable Diseases, SARS CoV 2 Infection",
      "COVID-19, Vaccine-Preventable Diseases, SARS CoV 2 Infection, Upper Respiratory Tract Infection, Upper Respiratory Disease",
      "Covid19",
      "Ebola",
      "Immunosuppression, COVID-19",
      "Influenza",
      "Influenza (Pandemic)",
      "Influenza, Human",
      "Malaria, Malaria,Falciparum",
      "Malaria,Falciparum",
      "Pandemic Influenza",
      "Respiratory Synctial Virus",
      "Respiratory Syncytial Virus (RSV)",
      "Respiratory Syncytial Virus Infections",
      "Respiratory Syncytial Viruses",
      "SARS-CoV Infection, Covid19",
      "SARS-CoV-2 Infection",
      "SARS-CoV-2 Infection, COVID-19",
      "Seasonal Influenza",
      "Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)",
      "Severe Acute Respiratory Syndrome Coronavirus 2 Infection"
    ],
    "lead_stage": "commercial"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:20:26.360882",
    "search_query": "Novavax, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Novavax,+Inc."
  }
}